ChartMill assigns a fundamental rating of 1 / 10 to APOP.
ChartMill assigns a valuation rating of 1 / 10 to Cellect Biotechnology Ltd ADR (APOP). This can be considered as Overvalued.
Cellect Biotechnology Ltd ADR (APOP) has a profitability rating of 0 / 10.
The financial health rating of Cellect Biotechnology Ltd ADR (APOP) is 2 / 10.